A recent study examined the possible effects of more access to cannabis on workplace injuries in younger workers.
In a recently published research letter, researchers from the University of Wisconsin-Parkside, San Diego State University, and Bentley University, examined how recreational cannabis laws affected workplace injuries, specifically for workers between the ages of 20 and 34 (1). They hypothesized that cannabis laws and use could be associated with more workplace injuries by decreasing cognition from increased cannabis use, or could be associated with fewer injuries if cannabis is being used to treat pain or as a substitute for other substances (1). The study, “Recreational Marijuana Legalization and Workplace Injuries Among Younger Workers,” was published in JAMA Health Forum on February 23, 2024 (1).
As noted in the study's introduction, states in the US are increasingly loosening cannabis restrictions: 24 states and Washington DC have made the sale and possession of certain amounts of cannabis legal as of 2012 (1). More research is needed on how this has affected workplace health and safety, the researchers stated (1).
Researchers used data from the Bureau of Labor Statistics Survey of Occupational Injuries and Illnesses to examine state-by-year data on workplace injury using an analysis sample of 632 state-year observations (1). They also adjusted for “dummy variables for each state and year, presence of a medical marijuana law, presence of a marijuana decriminalization or depenalization law, macroeconomic conditions, demographic characteristics, substance use policies, tobacco policies, per capita COVID-19 deaths, and the maximum workers compensation benefit,” (1).
The researchers concluded that a part of their hypothesis had been consistent with the results. “In this study, RMLs [recreational marijuana laws] that allow recreational marijuana sales were associated with a 10% increase in workplace injuries among individuals aged 20 to 34 years,” the researchers stated in the discussion section (1). In comparison, based on the decreased receiving of workers’ compensation benefits and of certain injuries, older workers may have benefitted from access to cannabis, the researchers suggested (1).
More research will be needed for analyzing the long-term effects of cannabis on workplace injuries, the researchers also noted (1).
For a deep dive into the complicated world of cannabis workplace health and safety, read more in “Cultivators Address New Health and Safety Issues for Plants and Workers” from our Tech Innovations column.
Also check out recent coverage of California’s new laws regarding cannabis use outside the workplace.
Reference
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Khan
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.